معرفی
Dr. Chithra Palani is an Assistant Professor at the Medical College of Georgia, Augusta University, with appointments in the Department of Pediatrics and the Georgia Cancer Center. Her work bridges pediatric hematology and cancer research, focusing on molecular interventions for sickle cell disease.
Research Interests: Dr. Palani's research program centers on therapeutic strategies to induce fetal hemoglobin (HbF) in sickle cell disease patients. She investigates small molecules and drug combinations—particularly histone deacetylase inhibitors (HDACi)—to activate γ-globin gene expression. Her work also extends into neuroinflammatory conditions, including optic neuritis and multiple sclerosis models, where she explores the role of arginase 2 in neurodegeneration.
Publications Trends: Her recent publications reflect a strong focus on translational molecular medicine, particularly in hemoglobinopathies and neuroinflammation. Common themes include gene regulation via miRNAs, stress-response pathways, and genetic knockout models to dissect disease mechanisms. The use of both in vitro erythroid progenitors and in vivo mouse models underscores a commitment to preclinical validation.
Scientific Contributions:
- Key work on Bach1 inhibitors and salubrinal as HbF inducers
- Elucidation of miRNA-29b’s role in globin switching
- Discovery of arginase 2 as a modulator of neuroinflammation and retinal damage
Advising and Grants: While no formal advisees or grant funding are mentioned in the available text, her active research portfolio suggests ongoing mentorship and external support. She likely supervises graduate students or postdoctoral researchers in molecular biology and translational therapeutics.
Labs and Research Teams: Dr. Palani is likely part of a multidisciplinary research team within the Georgia Cancer Center and the Department of Pediatrics, collaborating on hemoglobinopathy and neuroinflammation projects. Her work aligns with broader initiatives at Augusta University focused on health disparities and precision medicine in underserved populations.
